Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00982696 · ClinicalTrials.gov registry record · Phase 2
Treatment of Advanced Head and Neck Cancer
A Phase 2 study, sponsored by Milton S. Hershey Medical Center.
- Terminated
- Registry status
- Phase 2
- Development phase
- 5
- Enrollment target
NCT00982696 is a Phase 2 study that was terminated before completion, run by Milton S. Hershey Medical Center. The registered enrollment target is 5 participants.
The verdict
NCT00982696, a Phase 2 study, was terminated before completion, sponsored by Milton S. Hershey Medical Center.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 5 participants
- Enrollment target
Study Summary
This study will investigate the efficacy of opioid growth factor (OGF) on tumor size and survival in patients with head and neck cancer who have failed standard therapy.
Interventions
- BIOLOGICAL Opioid Growth Factor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2008-02 |
| Est. Completion | 2011-11 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00982696
The ClinicalTrials.gov registry entry for NCT00982696 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Milton S. Hershey Medical Center, which has 396 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Opioid Growth Factor is the first listed.
NCT00982696 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00982696 about?
NCT00982696 is a clinical study titled "Treatment of Advanced Head and Neck Cancer". This study will investigate the efficacy of opioid growth factor (OGF) on tumor size and survival in patients with head and neck cancer who have failed standard therapy.
What is the current status of trial NCT00982696?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 5 participants. The study started on 2008-02. Estimated completion is 2011-11.
What interventions are being tested in trial NCT00982696?
The interventions under investigation include: Opioid Growth Factor (BIOLOGICAL).
Who is sponsoring clinical trial NCT00982696?
This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.